vTv Therapeutics (NASDAQ:VTVT) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) in a research note issued to investors on Tuesday. The firm issued a sell rating on the biotechnology company’s stock. Separately, Alliance Global Partners initiated coverage on vTv Therapeutics in a research report on Monday, December 9th. They set a “buy” rating and […]
StockNews.com began coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) in a research note issued to investors on Tuesday. The firm issued a sell rating on the biotechnology company’s stock. Separately, Alliance Global Partners initiated coverage on vTv Therapeutics in a research report on Monday, December 9th. They set a “buy” rating and […]
